Lupus

Article	Citations
Long-term follow-up of autologous peripheral blood hematopoietic stem cell transplantation for refractory lupus nephritis—a series study of 20 patients	85
Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus	60
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort	52
Belimumab-induced periungual pyogenic granulomas: A case report	28
High density lipoprotein influences CD4 T cell proliferation in Systemic Lupus Erythematosus and increases TGF-β1 expression: A potential role in the protection from atherosclerosis and autoimmunity	28
Navigating the diagnostic maze: A case presentation of C1q vasculitis mimicking hypocomplementemic urticarial vasculitis in a patient with systemic lupus erythematosus	27
Corrigendum to The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations	26
The relation of CD4+CD25+Foxp3+ regulatory T cells concentration with disease activity and damage index in systemic lupus erythematosus	24
The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective	24
Neonatal lupus erythematosus: 24 years of experience from a tertiary centre at Chandigarh, North India	23
Macrophage activation syndrome as a presenting feature in juvenile systemic lupus erythematosus	23
Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus	23
Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays	23
Posterior reversible encephalopathy syndrome in juvenile lupus- a case series and literature review	22
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors	22
Bioinformatic analysis of key biomarkers and immune filtration of skin biopsy in discoid lupus erythematosus	21
Telomere length and its association with systemic lupus erythematosus in an Asian population: A Mendelian randomization study	19
Pilot study on accelerated aging in lupus using epigenetic biomarkers of age	18
Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark	18
Literature review of lupus nephritis From the Arabian Gulf region	18
Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE	17
Understanding the impact of systemic lupus erythematosus on work amongst South Asian people in the UK: An explorative qualitative study	17
Unsupervised clustering analysis of data from an online community to identify lupus patient profiles with regards to treatment preferences	16
The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity	16
The impact of pregnancy planning and medical readiness on reproductive outcomes in women with systemic lupus erythematosus	16

Hydroxychloroquine might reduce risk of incident endometriosis in patients with systemic lupus erythematosus: A retrospective population-based cohort study	16
Left ventricular diastolic dysfunction and diseases severity contribute to impaired exercise capacity in systemic lupus erythematosus	16
LncRNA NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	16
Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity——a multi-center retrospective study	16
Correlation between the changes of brain amplitude of low-frequency fluctuation and cognitive impairment in patients with neuropsychiatric lupus	16
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids	15
Early detect left ventricular subclinical myocardial dysfunction in patients with systemic lupus erythematosus by a left ventricular pressure-strain loop	15
Evaluation of health literacy and its association with medication adherence and quality of life in childhood-onset systemic lupus erythematosus	14
EBV load is associated with cfDNA fragmentation and renal damage in SLE patients	14
Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients	13
Vitamin B12 and primary antiphospholipid syndrome	13
Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature review	13
Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares	13
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus	13
Assessment of the association between TNIP1 polymorphism with clinical features and risk of systemic lupus erythematosus	13
Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy	13
Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review	13
Systemic lupus erythematosus on social networking sites: Friends or foes?	13
Immunohistochemical expression of perforin in adult systemic lupus erythematosus associated macrophage activation syndrome: Clinicohematological correlation and literature review	12
Patient experiences and strategies for coping with SLE: A qualitative study	12
Associations between physicians’ global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study	12
Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: Case report and literature review	12
Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study	12
High mobility group box protein 1 (HMGB1) serum and urinary levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus: A possible relation to lupus nephritis	12
Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels	12
Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus	11
Clinical disease activity index applicability in lupus arthropathy: Unraveling underdiagnosed joint activity	11
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controls	11
Sociodemographic profiles and organ damage accural in the Black Women’s Experience Living with Lupus study	11
Characteristics of SLE patients with symptomatic COVID-19: Single centre experience at Sultan Qaboos University Hospital over a 30-month period	11
The prognostic value of neutrophile/lymphocyte ratio and serum chemerin to predict maternal-fetal complications in pregnant systemic lupus erythematosus patients	11
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	11
Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study	11
Impact of miRNA-binding site polymorphisms in STAT3 gene on occurrence and clinical characteristics of systemic lupus erythematosus	11
Pediatric onset lupus nephritis in western India—is it different from the rest of the country?	11
Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping review	11
Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review	11
The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus erythematosus	10
Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case	10
Psychiatric comorbidities in patients suffering from systemic lupus erythematosus admitted to a tertiary care hospital in Northern India	10
Polyneuritis cranialis as a unique initial presentation of juvenile systemic lupus erythematosus: Case report	10
Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives	10
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	10
Improvement of lupus-associated fatigue with modafinil: Report of two cases	10
Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America	10
The high expression of miR-564 in patients with systemic lupus erythematosus promotes differentiation and maturation of DC cells by negatively regulating TP53 expression in vitro	10
Predictors for early readmission in patients hospitalized with new onset pediatric lupus nephritis	10
Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis	10
The effect of respiratory muscle training on respiratory muscle strength, diaphragm thickness/mobility, and exercise capacity in patients with systemic lupus erythematosus and associated shrinking lun	9
Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus	9

COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	9
Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus	9
Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome	9
Cardiac involvement in systemic lupus erythematosus: Interest of 2D global longitudinal strain	9
Long-term outcome of tacrolimus monotherapy in a patient with lupus nephritis: A 12-year observation	9
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort	9
Detection of genetic mutations underlying early-onset systemic lupus erythematosus	9
A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt	9
Helios-expressing CD8+ T cells are decreased in patients with systemic lupus erythematosus	9
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology	9
Antiphospholipid antibodies and idiopathic infertility	9
Neonatal Fc receptor expression in lymphoid and myeloid cells in systemic lupus erythematosus	9
Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life	9
Associations between blood IL-33 levels and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis	9
Does higher quality of care in systemic lupus erythematosus translate to better patient outcomes?	9
Parkinsonism as the presenting manifestation of lupus: A case-based review	9
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus	9
New-onset lupus nephritis associated with COVID-19 infection	9
Acute pericardial tamponade: The initial manifestation of systemic lupus erythematosus with Graves’ hyperthyroidism	8
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients	8
Systemic lupus international collaborating clinics-2012 and European league against rheumatism/American college of rheumatology-2019 classification criteria for systemic lupus erythematosus associated	8
Belimumab in subacute cutaneous lupus erythematosus	8
Association of regulatory T cells with renal outcomes in patients with proliferative lupus nephritis	8
Interest on the internet for systemic lupus erythematosus: Analysis of Google Trends in Latin American countries	8
Combined treatment of prednisone and hydroxychloroquine may improve outcomes of frozen embryo transfer in antinuclear antibody-positive patients undergoing IVF/ICSI treatment	8
The association between dietary patterns and a doctor diagnosis of systemic lupus erythematosus: the Adventist Health Study-2	8
Expression of caveolin family proteins in serum of patients with systemic lupus erythematosus	8
Fetal proximal and distal limb anomalies following exposure to mycophenolate mofetil during pregnancy: A case report and review of the literature	8
Abnormal presentation of pregnancy and postpartum initial-onset systemic lupus erythematosus combined with diffuse alveolar hemorrhage: A case report	8
Multidisciplinary approach to lupus nephritis: Clinical pearls, pitfalls, and positioning of newly-approved agents	8
Burden of lupus activity on health care resources utilization in Buenos Aires, Argentina	8
Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model	8
Cognitive dysfunction in patients with systemic lupus erythematosus. A cross-sectional study in a Brazilian sample	8
Efficacy and safety of belimumab in systemic lupus erythematosus patients with severe lupus nephritis requiring renal replacement therapy	8
Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it	8
Home monitoring of fetal heart rhythm: Lived experiences of women with anti-SSA/Ro52 autoantibodies and their co-parents	8
Beyond paraneoplastic neurological syndromes: Anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosus	8
Something new about prognostic factors for lupus nephritis? A systematic review	8
Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations	7
FKN secreted by kidney epithelial cells regulates macrophage activation in lupus nephritis via the Hippo signaling pathway	7
Unchanged trend in mortality from systemic lupus erythematosus during the 2020 COVID-19 pandemic: A nationwide population-based study	7
Childhood adverse experiences and clinical manifestations in women with systemic lupus erythematosus	7
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019	7
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis	7
Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS)	7
One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels	7
Immunoglobulin levels in systemic lupus erythematosus: A narrative review	7
Current smoking is related to severe damage in systemic lupus erythematosus patients	7
Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus	7
Comparison of late-onset and non-late-onset systemic lupus erythematosus individuals in a real-world electronic health record cohort	7
Positive psychological capital, post-traumatic growth, social support, and quality of life in patients with systemic lupus erythematosus: A cross-sectional study	7
Carriage prevalence, serotype distribution, and antimicrobial susceptibility among pneumococcal isolates recovered from adults with systemic lupus erythematosus	7
Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects	7
Air pollution influence on serum inflammatory interleukins: A prospective study in childhood-onset systemic lupus erythematous patients	7
Predictive factors of fetal and maternal pregnancy outcomes in Japanese patients with systemic lupus erythematosus	7
Dissociation in SLE: A part of lupus fog?	7
16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends	7
The challenges in diagnosing pediatric primary antiphospholipid syndrome	7
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review	7
Feasibility and preliminary data for a State-wide South Carolina Lupus Registry	7
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey	7
Plasma checkpoint protein levels and galectin-9 in juvenile systemic lupus erythematosus	7
Low disease activity state in juvenile-onset systemic lupus erythematosus	7
Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course	7
Treatment adherence and quality of life in colombian patients with lupus nephritis	7
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus	6
Pulmonary involvement: A potential independent factor for quality of life in systemic lupus erythematosus	6
ASIA syndrome with severe lupus – A case report	6
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications	6
Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients	6
Are autoimmune diseases autoinflammatory: Is it time to change the paradigm?	6
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study	6
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis	6
Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus	6
Clinical features and two-year outcomes in systemic lupus erythematosus patients with heart failure and reduced, mid-range and preserved ejection fractions	6
Association between serum uric acid level and systemic lupus erythematosus kidney outcome: An observational study in Southern Chinese population and a meta-analysis	6
Reversibility of pulmonary hypertension in systemic lupus erythematosus after induction immunosuppressive therapy: An inflammatory manifestation?	6
Assessment of renal response in Tunisian patients with proliferative lupus nephritis under three different induction immunosuppressive agents: A prognostic retrospective study	6
Disease features at diagnosis and changes in disease course severity among commercially insured patients with childhood-onset compared with adult-onset systemic lupus erythematosus	6
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab	6

Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review	6
Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis	6
Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus	6
The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome	6
Identification and analysis of the predictive urinary exosomal miR-195-5p in lupus nephritis based on renal miRNA-mRNA co-expression network	6
Erosive arthritis in systemic lupus erythematosus: not only Rhupus	6
Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients	6
Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report	6
Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies	6
Investigating how patients with lupus nephritis access and trust health information: Results from a Canadian survey of patients with lupus nephritis	6
The first use of “lupus” as a disease	6
Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells	6
Significant heightened methylation levels of RUNX3 gene promoter in patients with systemic lupus erythematosus	6
Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis	6
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis	6
Possible relationship between hydroxychloroquine and electrocardiographic and echocardiographic abnormalities in patients with inflammatory rheumatic diseases––a monocentric study	6
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis	6
Association of Human Leucocyte Antigen Class II, with viral load and immune response to Epstein–Barr virus in adult and pediatric Systemic lupus erythematosus patients	6
Impact of online health information-seeking behavior on shared decision-making in patients with systemic lupus erythematosus: The TRUMP2-SLE project	6
Letter re: Lupus erythematosus masquerading as acneiform lesions: two cases and review of the literature	6
Treatment outcomes in refractory lupus nephritis: Data from an observational study	6
Systemic lupus erythematosus patients have a distinct structural and functional skin microbiota compared with controls	6
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study	6
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies	6
Health care practitioners’ confidence assessing lupus-related rashes in patients of color	5
Lupus, vaccinations and COVID-19: What we know now	5
Development and psychometric properties of the Reproductive Health Assessment in Systemic Lupus Erythematosus: Mixed-Methods study	5
Dilated cardiomyopathy: An unusual and severe condition in juvenile systemic lupus erythematosus	5
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus	5
Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?	5
Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model teriflunomide in anti-ANXA2 mice model	5
Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis	5
A qualitative investigation of the experiences of patients living with antiphospholipid antibodies	5
Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan	5
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	5
The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study	5
Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia	5
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort	5
Depression in systemic lupus erythematosus: A manifestation of microcirculation dysfunction?	5
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score	5
Psychometric properties evaluation of the Persian version of the self-report outcome scale for lupus disease Lupus_PRO version 1.7	5
Withdrawal of “Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study”	5
Thanks to Reviewers	5
Beneficial effects associated to a healthy lifestyle in systemic lupus erythematosus: A cross-sectional study	5
Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus	5
Clinical algorithm model based on cfDNA to predict SLE disease activity	5
Alterations of the microbiome across body sites in systemic lupus erythematosus: A systematic review and meta-analysis	5
What you need to know about migraine in Hughes syndrome patients	5
Telehealth-supervised exercise in systemic lupus erythematosus: A pilot study	5
Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients – Analysis of the German LuLa study	5
Diagnostic value of salivary gland ultrasonography for secondary Sjögren syndrome in patients with systemic lupus erythematosus	5
ARID5B rs10821936 and rs10994982 gene polymorphism and susceptibility to juvenile systemic lupus erythematosus and lupus nephritis	5
Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study	5
Dr. Eng Meng Tan August 26, 1926 - March 9, 2024 La Jolla, California	5
Naomi Rothfield, MD, MACR 1929-2023	5
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome	5
Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort	5
Idiopathic intracranial hypertension as the initial presenting manifestation of systemic lupus erythematosus in a child	5
Refractory antiphospholipid antibody syndrome–induced thrombocytopaenia successfully treated with belimumab	5
Growth arrest-specific protein 6 as a marker of nephritis in systemic sclerosis and juvenile systemic lupus erythematosus patients	5
Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A “post-hoc” analys	5
Cardiovascular disease risk perceptions and influencing factors among Chinese systemic lupus erythematosus patients	5
Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study	4
2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A retrospective study over the last 29 years	4
A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus	4
Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus	4
Diffuse cerebral edema with leukoencephalopathy revealing systemic lupus erythematosus: A case report and review of literature	4
Pristane cadmium chloride nanoemulsion accelerates the onset of systemic lupus erythematosus in a C57BL/6 mouse model	4
Needs for discharge planning and facilitators-barriers to implementing discharge plans for patients with SLE: A qualitative study	4
Active lupus in Argentina: Results of a multicenter and national registry	4
Impact of perception of illness on quality of life in juvenile systemic lupus erythematosus	4
Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients	4
Health seeking behaviour and diagnostic delays in SLE: A multi-ethnic Malaysian cohort study	4
Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study	4
Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital	4
Association of juvenile systemic lupus erythematosus and retinal vasculitis: Genetic aspects	4
Glucocorticoid-free remission in patients with SLE in the era of biologics: Immune complex disease is likely to benefit from current medications	4
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis	4
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	4
Immature platelet levels correlate with disease activity and predict treatment response of thrombocytopenia in lupus patients	4
Interleukin 17A rs2275913 polymorphism is associated with susceptibility to systemic lupus erythematosus: A meta and trial sequential analysis	4
Phenotype and disease course differences in monogenic and sporadic childhood lupus	4
Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus	4
Skin erythematous migrant lesions consistent with histologically confirmed dermal arteriolar thrombosis connected to APS	4
Integrating spiritual disposition intervention into behavioral medicine: A case report on systemic lupus erythematosus from India	4
Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile	4
Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature	4
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review	4
Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel	4
2019 EULAR/ACR classification criteria for SLE score predicts future lupus hospital admission and costs	4
Lupus and SARS-CoV-2: What have we learned after the pandemic?	4
Trends in all-cause hospitalizations for systemic lupus erythematosus in Mexico, 2000–2019	4
Lupus nephritis: A focus on the United Arab Emirates and the potential role of genetics	4
Prevalence of juvenile systemic lupus erythematosus in Colombia: An approach from the national health registry data	4
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis	4